Alexza Is Meaningfully Overvalued Following Its Latest Rally

Published December 7, 2012

Alexza Is Meaningfully Overvalued Following Its Latest Rally

Filed under: drug treatment news 2010

21, 2012, the U.S. FDA is expected to rule on Alexza Pharmaceuticals' (ALXA) new drug application (NDA) for ADASUVE, the company's inhalation powder formulation of loxapine for the treatment of acute agitation in patients with schizophrenia and bipolar …
Read more on Seeking Alpha

SA's spectacular reversal in fight against Aids

Filed under: drug treatment news 2010

South Africa has witnessed an "unparalleled" five-year increase in life expectancy since 2005 thanks to the world's biggest programme of HIV/Aids drug treatment, researchers say. The trend marks a spectacular reversal from the days when former …
Read more on Mail & Guardian Online